NAS · US · ydesgroup.com
0.3700USD+48.00%Mkt Cap: —P/E: —2d ago
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The c…
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)510.36K $
Gross Profit167.41K $
Net Income (TTM)-8.31M $
Revenue/Share0.4660 USD
Last Price0.3700 USD
Fiscal Year End—
MR Quarter—
Employees—
CountryUS
Sector—
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.08
EPS (TTM)—
EPS (Forward)—
52W Range
0.191332% of range0.7500
52W High0.7500 USD
52W Low0.1913 USD
Profitability
Gross Margin28.05%
Oper. Margin-444.59%
EBITDA Margin-265.93%
Profit Margin-1392.61%
ROE291.05%
ROA-60.32%
Growth
Revenue Growth95.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.60M $
CapEx (TTM)1.44M $
FCF Margin-759.38%
FCF Yield—
Net Debt-3.11M $
Net Debt/EBITDA2.29
Balance Sheet
Debt/Equity-0.00
Current Ratio13.18
Quick Ratio12.91
Book Value/Sh4.571 USD
Cash/Share2.173 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float319.74K
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta-0.13
S&P 52W Chg18.16%
Avg Vol (30d)3.26K
Avg Vol (10d)—
Technical Indicators
RSI (14)42.5
MACD-0.1031
MACD Signal-0.0797
MACD Hist.-0.0234
BB Upper0.9701 USD
BB Middle0.5397 USD
BB Lower0.1094 USD
BB Width159.48%
ATR (14)0.0914 USD
Vol Ratio (20d)13.47x